发明名称 |
ADMINISTRATION OF TLR7 LIGANDS AND PRODRUGS THEREOF FOR TREATMENT OF INFECTION BY HEPATITIS C VIRUS |
摘要 |
This invention relates to methods for treating or preventing hepatitis C virus infections in mammals using Toll-Like Receptor (TLR)7 ligands and prodrugs thereof. More particularly, this invention relates to methods of orally administering a therapeutically effective amount of one or more prodrugs of TLR7 ligands for the treatment or prevention of hepatitis C viral infection. Oral administration of these TLR7 immunomodulating ligands and prodrugs thereof to a mammal provides therapeutically effective amounts and reduced undesirable side effects.
|
申请公布号 |
CA2537450(C) |
申请公布日期 |
2012.04.17 |
申请号 |
CA20042537450 |
申请日期 |
2004.09.01 |
申请人 |
ANADYS PHARMACEUTICALS, INC. |
发明人 |
AVERETT, DEVRON R. |
分类号 |
A61K31/708;A61K31/4745;A61K31/513;A61K31/522;A61K31/7076;A61P31/14 |
主分类号 |
A61K31/708 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|